7-Hydroxyquinolinone CAS 70500-72-0 Purity >98.0% (HPLC) Brexpiprazole Intermediate Factory

Short Description:

Chemical Name: 7-Hydroxyquinolinone

Synonyms: 2,7-Dihydroxyquinoline

CAS: 70500-72-0

Purity: >98.0% (HPLC)

Appearance: White to Yellow Solid

Intermediate of Brexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-one CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3

Chemical Properties:

Chemical Name	7-Hydroxyquinolinone
Synonyms	2,7-Dihydroxyquinoline; 7-Hydroxy-1,2-Dihydroquinolin-2-one; 7-Hydroxyquinolin-2(1H)-one; 3,4-Dihydro-7-Hydroxycarbostyril; 7-Hydroxycarbostyril
CAS Number	70500-72-0
CAT Number	RF-PI1979
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C9H7NO2
Molecular Weight	161.16
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	White to Yellow Solid
Purity / Analysis Method	>98.0% (HPLC)
Infrared Spectrum	Conforms to Structure
Proton NMR Spectrum	Conforms to Structure
Loss on Drying	<1.00%
Heavy Metals	<0.002%
Total Impurities	<2.0%
Shelf Life	2 Years
Test Standard	Enterprise Standard
Usage	Intermediate of Brexpiprazole (CAS: 913611-97-9)

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

FAQ:

Application:

7-Hydroxyquinolinone (CAS: 70500-72-0) is a substituted carbostyril derivative as pharmaceutical intermediate. 7-Hydroxyquinolinone is an intermediate of Brexpiprazole (CAS: 913611-97-9). Brexpiprazole is a drug candidate useful in treatment and prevention of mental disorders including CNS disorders. Brexpiprazole is a kind of atypical antipsychotic. It is a dopamine D2 receptor partial agonist. As a novel serotonin-dopamine activity modulator, Brexpiprazole can be used for the treatment of schizophrenia, and for the adjunctive treatment for depression. Brexpiprazole can also provide efficacy and tolerability over established adjunctive treatments formajor depressive disorder (MDD). Recent study has also suggested Brexpiprazole can ameliorate PCP-induced cognitive deficits in mice via 5-HT1A receptors.